Patent Classification

Drug Delivery System, Impulse Transients

1. Compound delivery using impulse transients

Drug Delivery System, Infusion

1. Administering a gravity segregation dispersion by continuous infusion
    
2. Catheter flush solution and method for its use
    
3. Substitution infusion fluid and citrate anticoagulation
    
4. Oxybutynin formulations and method of use

Drug Delivery System, Inhalation/Nasal/Intranasal/Respiratory/ Nebulization

1. Delivery of drug amines through an inhalation route
    
2. Delivery of drug esters through an inhalation route
    
3. Method and composition for delivering zinc to the nasal membrane
    
4. Fluticasone propionate nasal pharmaceutical formulations and methods of using same
    
5. Inhalable epinephrine
    
6. Methods of transnasal transport/immunization with highly adaptable carriers
    
7. Respiratory dispersion for metered dose inhalers
    
8. Dry powder inhalation system for transpulmonary administration
    
9. Intranasal vaccine for use against disease caused by enterotoxigenic Escherichia coli
    
10. System for delivering a composition to the nasal membrane and method of using the same
     
11. Powdery preparation for nasal administration
     
12. Methods and compositions for nasal administration of modafinil
     
13. Nasal calcitonin formulation 
     
14. Hypertonic solutions and method of treatment
     
15. Therapeutic compositions for intranasal administration which include KETOROLAC
     
16. Administration of medicinal dry powders
     
17. Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
     
18. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
     
19. High storage stability inhalable compositions
     
20. Vaccine compositions including chitosan for intranasal administration and use thereof
     
21. Therapeutic compositions for intranasal administration which include KETOROLAC
     
22. Use of microparticles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration
     
23. Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
     
24. Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone
     
25. Modified carrier particles for use in dry powder inhalers
     
26. Transnasal anticonvulsive compositions and modulated process
     
27. Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides
     
28. Dry power inhaler excipient, process for its preparation and pharmaceutical compositions containing it
     
29. Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component
     
30. Carrier particles for use in dry powder inhalers
     
31. Formulations of steroid solutions for inhalatory administration
     
32. Nasal spray formulation and method
     
33. Pernasally absorbable insulin preparations
     
34. Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets
     
35. Powdery composition for nasal administration
     
36. Inactivated influenza virus vaccine for nasal or oral application
     
37. Electrostatically charged nasal application product with increased strength
     
38. Pulmonary administration of chemically modified insulin
     
39. Powder Composition for nasal administration
     
40. Nasal spray compositions
     
41. Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides
     
42. Compositions for inhalation
     
43. Nasal administration of agents for the treatment of gastroparesis
     
44. Nasal delivery of apomorphine
     
45. Inhalatory compositions of Formoterol
     
46. Methods comprising intranasal morphine
     
47. Method and composition for delivering zinc to the nasal membrane
     
48. Nasal solution containing a broad spectrum microbicide and a method for its use
     
49. Formulation for respiratory tract administration
     
50. Inactivated influenza virus vaccine for nasal or oral application
     
51. Aerodynamically light particles for pulmonary drug delivery
     
52. Compositions for inhalation
     
53. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
     
54. Nasally administrable compositions
     
55. Spray drying of macromolecules to produce inhaleable dry powders
     
56. Fat emulsions for inhalational administration
     
57. Carrier particles for use in dry powder inhalers
     
58. Pulmonary delivery in treating disorders of the central nervous system
     
59. Metered dose inhaler for beclomethasone dipropionate
     
60. Aerodynamically light particles for pulmonary drug delivery
     
61. Stable powder inhalation dosage formulation
     
62. Powders comprising anti-adherant materials for use in dry powder inhalers
     
63. Budesonide particles and pharmaceutical compositions containing them
     
64. Process for the preparation of suspensions of drug particles for inhalation delivery
     
65. Carbon dioxide enhancement of inhalation therapy
     
66. Nasal calcitonin formulations
     
67. Nasal delivery of apomorphine
     
68. Porous particles comprising excipients for deep lung delivery
     
69. Powdery nasal compositions
     
70. Formulation and method for treating neoplasms by inhalation
     
71. Pharmaceutical composition using a mixture of propellant gases for a metered dose inhaler
     
72. Powder inhaler
    
    
73. Compositions for nasal administration 
    
    
74. Method for administering fibroblast growth factor to the brain 
    
    
75. Intranasal yellow fever vaccination
     
    
76. Therapeutic compositions for intranasal administration which include KETOROLAC.RTM.
     
    
77. Powder inhaler
     
    
78. Method for administering insulin to the brain
     
    
79. Stabilized preparations for use in metered dose inhalers
     
    
80. Therapeutic preparation for inhalation
     
    
81. Particulate formulation for administration by inhalation
     
    
82. Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
     
    
83. Sonic nebulized nucleic acid/cationic liposome complexes and methods for pulmonary gene delivery
     
    
84. Xylitol nose spray
     
    
85. Porous particles for deep lung delivery
     
    
86. Use of inhaled retinoids in the prevention of cancer
     
    
87. Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
     
    
88. Inhaler
     
    
89. Process for the preparation of respirable particles
     
    
90. Pulmonary delivery of protonated/acidified nucleic acids
     
    
91. Particles incorporating surfactants for pulmonary drug delivery
     
    
92. Powdered pharmaceutical formulations having improved dispersibility
     
    
93. Mometasone furoate suspensions for nebulization
     
    
94. Inhalation composition containing lactose pellets
     
    
95. Method for administering neurologic agents to the brain
     
    
96. Therapeutic nasal inhalant
     
    
97. Iodine-containing nasal moisturizing saline and mouthwash solutions
     
    
98. Therapeutic preparation for inhalation
     
    
99. Fluorocarbon compositions for pulmonary therapy
     
    
100. Container for an inhalation anesthetic
      
     
101. Method for enhanced brain delivery of bupropion
      
     
102. Metered dose inhaler for salmeterol
      
     
103. Aqueous-based pharmaceutical composition
      
     
104. Powdered pharmaceutical formulations having improved dispersibility
      
     
105. Biocompatible compounds for pharmaceutical drug delivery systems
      
     
106. Delivery method for recombinant raccoon poxvirus
      
     
107. Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine
      
     
108. Inhalation therapy decongestant with foraminous carrier
      
     
109. Pulmonary delivery of active fragments of parathyroid hormone
      
     
110. Pulmonary and nasal delivery of raloxifene
      
     
111. Method and composition for delivering zinc to the nasal membrane
      
     
112. Nasal administration of benzodiazepine hypnotics
      
     
113. Container for an inhalation anesthetic
      
     
114. Inhaler for powdered medicaments
      
     
115. Pulmonary delivery of pharmaceuticals
      
     
116. Solidified drug supply for generating inhalable drug particles
      
     
117. Xylitol delivery
      
     
118. Method for administering acylated insulin
      
     
119. Powders for inhalation
      
     
120. Formulation for inhalation
      
     
121. Formulation for inhalation
      
     
122. Fatty acid -- pulmonary surfactant conjugates
      
     
123. Dispersible antibody compositions and methods for their preparation and use
      
     
124. Formulation for intranasal administration
      
     
125. Nasal melatonin composition
      
     
126. Nasal spray (drop) for treating fever/cold, and its preparation
      
     
127. Powder formulations containing melezitose as a diluent
      
     
128. Methods and compositions for pulmonary delivery of insulin
      
     
129. Preparation of particles for inhalation
      
     
130. Formulation for inhalation
      
     
131. Pharmaceutical composition for inhalation containing CR 2039 (Andolast)
      
     
132. Aqueous-based pharmaceutical composition
      
     
133. Ultrafine particle power for inhalation and method for production thereof
      
     
134. Pharmaceutical compositions of uridine triphosphate
      
     
135. Processes for preparing compositions for inhalation
      
     
136. Herbal based nasal spray
      
     
137. Medicaments for nasal administration
      
     
138. Pharmaceutical compositions for intranasal administration of dihydroergotamine
      
     
139. Nasal drug delivery composition containing nicotine

Drug Delivery System, Interferon

1. IFN-.beta. liquid formulations
    
2. Utilization of interferon alpha 5 in the treatment of viral hepatopathies
    
3. Orally-administered interferon-tau compositions and methods
    
4. Population of interferon producing cells
    
5. Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases
    
6. HSA-free formulations of interferon-beta
    
7. Methods for enhancing the production of interferon in cell culture
    
8. IFN-.beta. liquid formulations
    
9. Ribavirin-pegylated interferon alfa induction HCV combination therapy
    
10. Interferon-beta fusion proteins and uses
     
11. Process for purifying human leukocyte interferon
    
    
12. Interferon-gamma (IFN-.gamma.) inducing factor (IGIF, IL-18) and peptide fragment thereof
     
    
13. Low-toxicity human interferon-alpha analogs

Drug Delivery System, Intracellular Delivery

1. Intracellular delivery of osteoinductive proteins and peptides
    
2. Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest
    
3. Intracellular pharmaceutical targeting
   
   
4. Method of intracellular binding target molecules
    
   
5. Intracellular delivery vehicles 
    
   
6. Conjugates targeted to the interleukin-2 receptor
    
   
7. Active agent transport systems
    
   
8. Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles
    
   
9. Materials and methods for intracellular delivery of biologically active molecules
    
   
10. Materials and methods for the intracellular delivery of substances

Drug Delivery System, Intravaginal/Intrauterine

1. Coated vaginal device for delivery of anti-migraine and anti-nausea drugs
    
2. Vaginal pharmaceutical compositions and methods for preparing them
    
3. Pharmaceutical preparation for the treatment of gynecological diseases
    
4. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
    
5. Drug delivery device, especially for the delivery of gestodene
    
   
6. Pharmaceutical product for application to uterus mucosa
    
   
7. Intravaginal preparation containing physiologically active peptide
    
8. Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in the vagina and the use thereof
    
9. Intravaginal drug delivery devices for the administration of an antimicrobial agent
    
10. Bioadhesive drug delivery system
     
11. Tampon for the treatment of Streptococcus Group B infections of the vagina
     
12. Biodegradable microbicidal vaginal barrier device
     
13. Intravaginal drug delivery system and discharge collection device
     
    
14. Prolonged release bioadhesive vaginal gel dosage form
     
    
15. Intravaginal drug delivery device
     
    
16. Vaginal suppository vaccine for urogenital infections
     
    
17. Use of polycarboxylic acid polymers to treat vaginal infections
     
    
18. Vaginal pharmaceutical compositions

Drug Delivery System, Intravesical

1. Intravesical drug delivery system
    
2. Intravesical drug delivery

Drug Delivery System, Ionotophoretic/Electrotransport/Electroporation

1. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
    
2. Iontophoresis apparatus
    
3. Iontophoretic device and method of delivery of active agents to biological interface
    
4. Apparatus for electroporation mediated delivery for drugs and genes
    
5. Compositions for electroporation
    
6. Tissue electroperforation for enhanced drug delivery
    
7. Compositions for drug administration by electroporation
    
8. Iontophoresis disc pain blocker
    
9. Percutaneous absorption promoters for electroporation
    
10. Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
     
11. Selected drug delivery profiles using competing ions
    
    
12. Device for sampling substances using alternating polarity of iontophoretic current
     
    
13. Formulation for electrically assisted delivery of lidocaine and epinephrine
     
    
14. Electrically assisted transdermal method and apparatus for the treatment of erectile dysfunction
     
    
15. Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
     
    
16. Iontophoresis device structure
     
    
17. Apparatus for electroporation mediated delivery of drugs and genes
     
    
18. Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
     
    
19. Stereospecific delivery of a drug using electrotransport
     
    
20. Iontophoretic transdermal delivery device
     
    
21. Device for enhanced electrotransport agent delivery
     
    
22. Liposomal delivery by iontophoresis
     
    
23. Electrotransport system with ion exchange material competitive ion capture
     
    
24. Composition and method of enhancing electrotransport agent delivery (Patent 5,990,179)
     
    
25. Composition and method of enhancing electrotransport agent delivery (Patent 5,985,316)
     
    
26. Iontophoretic delivery of cell adhesion inhibitors

Drug Delivery System, Ion-Exchange

1. Sustained release ophthalmic, otic and nasal suspension
    
2. Nicotine-containing, controlled release composition and method
    
3. Anionic exchange polymer complexes of buspirone
    
   
4. Antitussive drugs delivered by ion exchange resins (*Medium sized document -- long loading time)

Drug Delivery System, Laser Assisted

1. Laser assisted pharmaceutical delivery and fluid removal

Drug Delivery System, Layered Dosage Form

1. Modified release dosage form
    
2. Formulation and process for drug loaded cores
    
3. Multilayer pharmaceutical product for release in the colon
    
4. Oral pulsed dose drug delivery system
    
5. Method of treating a bacterial infection comprising administering amoxycillin
    
   
6. Composition containing an acid-labile benzimidazole and process for its preparation
    
   
7. Immobilized lipid-bilayer materials
    
   
8. Method of making a pharmaceutical dosage form comprising a proton pump inhibitor